HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Beauty Care Division Sales Jump 10% In Q4 On Olay, Hair Care

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble's beauty care division sales jumped 10% to $3.08 bil. in the fiscal fourth quarter (ended June 30), led by a strong performance of Olay skin care and volume growth in hair care, P&G said during a July 31 fourth quarter analyst call

You may also be interested in...



P&G New Year’s Resolution Includes Restaging Daily Renewal, Infusium 23

Procter & Gamble will continue to overhaul the brands it acquired under the Clairol umbrella with the relaunch of Daily Renewal and Infusium 23, according to P&G Global Personal Beauty Care President Susan Arnold. The company is planning to restage the brands early next year, she added

P&G New Year’s Resolution Includes Restaging Daily Renewal, Infusium 23

Procter & Gamble will continue to overhaul the brands it acquired under the Clairol umbrella with the relaunch of Daily Renewal and Infusium 23, according to P&G Global Personal Beauty Care President Susan Arnold. The company is planning to restage the brands early next year, she added

Olay Regenerist Skin Care To Debut Based On Cell Renewal Technology

Olay Regenerist is bowing as a next generation anti-aging skin care range that "regenerates" skin's outer layer one cell at a time, Procter & Gamble said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011411

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel